Product Liability
Aug. 5, 2006
Merck Learning How to Reach Juries, Observers Say
LOS ANGELES - Merck & Co's win in California's first Vioxx liability trial on Wednesday, the fifth defense verdict in eight trials, shows the pharmaceutical giant has honed a theme that works with juries, despite the company's taking some significant hits in the court of public opinion, legal observers said.
Daily Journal Staff Writer
LOS ANGELES - Merck & Co's win in California's first Vioxx liability trial on Wednesday, the fifth defense verdict in eight trials, shows the pharmaceutical giant has honed a theme that works with juries, despite the company's taking some significant hits in the court of public opinion, legal observers said.
The win also appears to be a significant step ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In